Author Question: Which of the following statements most accurately describes the etiology of substance-related ... (Read 95 times)

nelaaney

  • Hero Member
  • *****
  • Posts: 560
Which of the following statements most accurately describes the etiology of substance-related disorders?
 
  A) Substance-related disorders result from the interplay of biologic, genetic, and psychosocial factors.
  B) Substance-related disorders are primarily a result of the presence of an individual's inherently addictive personality.
  C) The primary predictors of substance-related disorders are childhood trauma and parental abuse or neglect.
  D) Substance abuse is a learned behavior.

Question 2

After a long history of intravenous heroin use, a client has expressed willingness to stop using heroin. The nurse would expect the client to receive which medication to decrease the severity of withdrawal?
 
  A) Methadone
  B) Gabapentin (Neurontin)
  C) Amphetamines
  D) Ondansetron (Zofran)



wfdfwc23

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

Ans: A
Substance-related disorders have a complex etiology, and contributions have been noted from a combination of neurological, genetic, behavioral, and sociocultural sources.

Answer to Question 2

Ans: A
Methadone is given to clients who abuse opioids and synthetic substances to replace their usual substance of abuse because it decreases the severity of withdrawal.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

Eating food that has been cooked with poppy seeds may cause you to fail a drug screening test, because the seeds contain enough opiate alkaloids to register as a positive.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library